EnzMed (Nanjing) Co., Ltd. ( China (Mainland))

EnzMed (Nanjing) Co., Ltd. is a biopharmaceutical company specialized in the research, development, manufacturing and marketing of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and biochemical reagents. Its main products include DL-4-Fluorophenylalanine with cas registry number of 51-65-0, 2-Methyl-5-isopropylbenzenesulfonic acid with cas registry number of 96-71-9, 3-Bromo-4-methoxybenzoic acid with cas registry number of 99-58-1, 2,2'-Bis(trifluoromethyl)benzidine with cas registry number of 341-58-2, 2,4-Dimethylbenzenesulfonyl chloride with cas registry number of 609-60-9, and so on.

EnzMed can provide novel and cost-effective solutions to pharmaceutical process development and manufacturing of chiral APIs by its integrated chiral technology platform that combines biotransformation and asymmetric synthesis.